Next Article in Journal
A Radionuclide Generator of High-Purity Bi-213 for Instant Labeling
Next Article in Special Issue
Effective Osteogenic Priming of Mesenchymal Stem Cells through LNA-ASOs-Mediated Sfrp1 Gene Silencing
Previous Article in Journal
Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States
Previous Article in Special Issue
Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects
 
 
Review

Article Versions Notes

Pharmaceutics 2021, 13(6), 913; https://doi.org/10.3390/pharmaceutics13060913
Action Date Notes Link
article xml file uploaded 21 June 2021 07:29 CEST Original file -
article xml uploaded. 21 June 2021 07:29 CEST Update https://www.mdpi.com/1999-4923/13/6/913/xml
article pdf uploaded. 21 June 2021 07:29 CEST Version of Record https://www.mdpi.com/1999-4923/13/6/913/pdf
article supplementary file uploaded. 21 June 2021 07:29 CEST - https://www.mdpi.com/1999-4923/13/6/913#supplementary
article html file updated 21 June 2021 07:30 CEST Original file -
article html file updated 27 July 2022 01:08 CEST Update https://www.mdpi.com/1999-4923/13/6/913/html
Back to TopTop